Literature DB >> 26668778

Prediction of prognosis of ALS: Importance of active denervation findings of the cervical-upper limb area and trunk area.

Yoko Sato1, Eiji Nakatani2, Yasuhiro Watanabe3, Masanori Fukushima2, Kenji Nakashima3, Mari Kannagi4, Yasuhiro Kanatani5, Hiroshi Mizushima6.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a motor neuron disease characterized by serious muscle atrophy and weakness. The purpose of this study was to find prognostic factors in patients with mild ALS using application forms for the Specified Disease Treatment Research Program in Japan. We classified ALS as mild, moderate and severe. The subjects consisted of 363 patients with mild ALS who underwent needle electromyography at registration and were followed for more than one year. Time to progression to severe ALS and time to deterioration of activities of daily living such as speech dysfunction, upper limb dysfunction, and walking disability were used as outcomes. Cox proportional hazards model analysis was performed to identify prognostic factors. Of the patients with initially mild ALS, 38.3% (139/363) had progressed severe ALS at the last follow-up. In multivariate analysis of time to progression to severe ALS, bulbar onset (hazard ratio [95% confidence interval]: 1.68 [1.13-2.49], p = 0.010), tongue atrophy (1.69 [1.14-2.51], p = 0.009), dyspnea (1.57 [1.02-2.41], p = 0.042) and active denervation findings (ADFs) of the cervical-upper limb area (1.81 [1.25-2.63], p = 0.002) emerged as prognostic factors. Furthermore ADFs in the trunk area were prognostic factors for upper limb dysfunction and walking disability (1.72 [1.05-2.81], p = 0.031, and 1.97 [1.09-3.59], p = 0.026). In conclusion ADFs of the cervical-upper limb area and trunk area were prognostic factors in ALS patients.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; bulbar onset; denervation findings; needle electromyography; prognostic factors

Year:  2015        PMID: 26668778      PMCID: PMC4660859          DOI: 10.5582/irdr.2015.01043

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  26 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Shortening the time to diagnosis in ALS: the role of electrodiagnostic studies.

Authors:  M Swash
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-03

Review 3.  The basics of electromyography.

Authors:  K R Mills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

4.  Needle electromyography.

Authors:  Ernest Johnson
Journal:  Muscle Nerve       Date:  2009-10       Impact factor: 3.217

5.  Developing an electronic health record for intractable diseases in Japan.

Authors:  Eizen Kimura; Shinji Kobayashi; Yasuhiro Kanatani; Ken Ishihara; Tsuneyo Mimori; Ryousuke Takahashi; Tsutomu Chiba; Hiroyuki Yoshihara
Journal:  Stud Health Technol Inform       Date:  2011

6.  Higher risk of complications in odynophagia-associated dysphagia in amyotrophic lateral sclerosis.

Authors:  Karen Fontes Luchesi; Satoshi Kitamura; Lucia Figueiredo Mourão
Journal:  Arq Neuropsiquiatr       Date:  2014-03       Impact factor: 1.420

7.  [Fasciculation potentials in ALS-significance, and relationship with clinical features].

Authors:  Kota Bokuda; Toshio Shimizu
Journal:  Rinsho Shinkeigaku       Date:  2014

Review 8.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

Review 9.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

10.  Prognostic value of decreased tongue strength on survival time in patients with amyotrophic lateral sclerosis.

Authors:  J G Weikamp; H J Schelhaas; J C M Hendriks; B J M de Swart; A C H Geurts
Journal:  J Neurol       Date:  2012-04-24       Impact factor: 4.849

View more
  4 in total

1.  Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.

Authors:  Samir Abu-Rumeileh; Veria Vacchiano; Corrado Zenesini; Barbara Polischi; Silvia de Pasqua; Enrico Fileccia; Angela Mammana; Vitantonio Di Stasi; Sabina Capellari; Fabrizio Salvi; Rocco Liguori; Piero Parchi
Journal:  J Neurol       Date:  2020-02-25       Impact factor: 4.849

Review 2.  What causes amyotrophic lateral sclerosis?

Authors:  Sarah Martin; Ahmad Al Khleifat; Ammar Al-Chalabi
Journal:  F1000Res       Date:  2017-03-28

3.  Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012.

Authors:  Takashi Yamauchi; Machi Suka; Chikako Nishigori; Hiroyuki Yanagisawa
Journal:  Orphanet J Rare Dis       Date:  2019-07-05       Impact factor: 4.123

4.  National Registry of Designated Intractable Diseases in Japan: Present Status and Future Prospects.

Authors:  Yasuhiro Kanatani; Naoko Tomita; Yoko Sato; Akiko Eto; Hiroe Omoe; Hiroshi Mizushima
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-09-21       Impact factor: 1.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.